Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1253-1258

  Kuwana, Masataka ^a   Sato, Shinichi ^b   Kikuchi, Kanako ^c   Kawaguchi, Yasushi ^d   Fujisaku, Atsushi ^e   Misaki, Yoshikata ^c   Hatamochi, Atsushi ^f   Kondo, Hirobumi ^g   Takehara, Kazuhiko ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e Tomakomai City General Hospital   (Japan)

^f CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Functional Disability; Hand Extension; Systemic Sclerosis Health Assessment Questionnaire; Total Skin Score

Indexed keywords

ADULT; AGED; ARTICLE; CALCINOSIS; DISABILITY; EATING; ERYTHROCYTE SEDIMENTATION RATE; ETHNOLOGY; EVALUATION; FEMALE; FINGER; FLEXION CONTRACTURE; HAND GRIP; HAND MOVEMENT; HUMAN; JAPAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF EXAMINATION; SOCIOLOGY; STUDENT T TEST; SYSTEMIC SCLEROSIS; UNITED STATES;

ADULT; AGED; CROSS-SECTIONAL STUDIES; CULTURAL CHARACTERISTICS; DISABILITY EVALUATION; EVALUATION STUDIES; FEMALE; HAND; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0037981259     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. In: Koopman WJ, editor. Arthritis and allied conditions. 13th ed. Baltimore: Williams & Wilkins; 1997:1433-64.
2. Clements PJ, Lachenbruch PA, Seibold JR, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
3. White B, Bauer EA, Goldsmith LA, et al. Guidelines for clinical trials in systemic sclerosis (scleroderma): I. Disease-modifying interventions. Arthritis Rheum 1995;38:351-60.
4. Seibold JR, McCloskey DA. Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Curr Opinion Rheumatol 1997;9:571-5.
5. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
6. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991;4:27-31.
7. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
8. Clements PJ, Wong WK, Hurwitz EL, et al. Correlates of the disability index of the Health Assessment Questionnaire: A measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999;42:2372-80.
9. Clements PJ, Wong WK, Hurwitz EL, et al. The disability index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 2001;44:653-61.
10. Moser DK, Clements PJ, Brecht ML, Weiner SR. Predictors of psychosocial adjustment in systemic sclerosis: the influence of formal education level, functional ability, hardiness, uncertainty, and social support. Arthritis Rheum 1993;36:1398-405.
11. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 1995;8:189-93.
12. Roca RP, Wigley FM, White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 1996;39:1035-40.
13. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999;42:465-74.
14. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
15. Tan EM, Cohan AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
19. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83.
20. Kawai S, Matsushita Y, Yoshida T, Akama H, Amano K, Yamada H. Measurement of quality of life in rheumatoid arthritis [in Japanese]. Ryumachi 1991;31:502-10.